Among the ETF’s components, Bristol-Myers Squibb stands out with the highest trading volume, showing an increase of approximately 1.3%. So far, over 7.2 million shares of Bristol-Myers have changed hands during this session. In contrast, Pfizer is down about 0.6%, with more than 5.5 million shares traded. Arvinas is leading the pack with a remarkable gain of around 5.5% on the day, while Marinus Pharmaceuticals is lagging behind, trading lower by about 4%.
VIDEO: Wednesday’s ETF with Unusual Volume: XPH
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.